EUVIMEDEuropean Health Evidence
Uhr Sources10/10 Journal Tree
Easy Demo

European Health Evidence

The European alternative to PubMed

EUVIMED is the European alternative to PubMed: a central, multilingual research platform for medicine, nursing, life sciences and healthcare. It brings together international and European literature sources, study registries, open-access full texts, citations and retraction notices in one search. Unlike pure bibliographic databases, EUVIMED supports the entire research process – from discovery and appraisal with LIVIA and CLARA to traceable evidence synthesis. European in focus, transparent, interoperable and designed for science and healthcare.

EuropeanMultilingualInteroperableTraceable

EUVIMED BETA

EUVIMED is currently in beta

EUVIMED is under continuous development. Features, data coverage and presentation may change or be temporarily incomplete.

Results are beta

Search results, classifications, summaries and AI-assisted assessments may be incomplete, delayed or incorrect.

Check original sources

Do not use EUVIMED results without verification for diagnosis, treatment or other clinical decisions. Always consult the original source and applicable guidelines.

Errors and feedback help us improve EUVIMED: info@euvimed.com

Lokaler Crossref-Datenbestand · journal-article

Healthcare resource utilization and cost of invasive pneumococcal disease, pneumonia, and acute otitis media in commercially and medicaid-insured children by risk group in the United States, 2018 to 2023

Salini Mohanty, Nicolae Done, Yan Song, Travis Wang, Abigail Zion, Emily Reichert, Tayler Li, Meghan White, Kelsie Cassell, Yi-Ling Huang, Kelly D. Johnson, Natalie Banniettis, Jessica P. Weaver, Kristen A. Feemster

Pneumonia · 2026

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Abstract Background Pneumococcal disease (PD) is a leading cause of morbidity among US children, particularly those with chronic medical conditions (CMC) and immunocompromising conditions (IC), and the decline in PD incidence was less pronounced in the late pneumococcal conjugate vaccine (PCV) 13 period. This study quantified healthcare resource utilization (HCRU) and costs among commercially and Medicaid-insured children with PD. Methods This retrospective observational cohort study used Merative™ MarketScan® Commercial Database and Multi-State Medicaid Databases to identify children with invasive pneumococcal disease (IPD), all-cause pneumonia (ACP), and acute otitis media (AOM) episodes using inpatient and outpatient claims. HCRU and costs per PD episode were assessed in the commercially and Medicaid-insured populations, stratified by age (

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Salini Mohanty, Nicolae Done, Yan Song, Travis Wang, Abigail Zion, Emily Reichert, Tayler Li, Meghan White, Kelsie Cassell, Yi-Ling Huang, Kelly D. Johnson, Natalie Banniettis, Jessica P. Weaver, Kristen A. Feemster
Quelle
Pneumonia
Publikation
2026-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
2200-6133
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Salini Mohanty, Nicolae Done, Yan Song, Travis Wang, Abigail Zion, Emily Reichert, Tayler Li, Meghan White, Kelsie Cassell, Yi-Ling Huang, Kelly D. Johnson, Natalie Banniettis, Jessica P. Weaver, Kristen A. Feemster (2026). Healthcare resource utilization and cost of invasive pneumococcal disease, pneumonia, and acute otitis media in commercially and medicaid-insured children by risk group in the United States, 2018 to 2023. Pneumonia. https://doi.org/10.1186/s41479-026-00206-1
RIS BibTeX CSL-JSON

Kontext

Themen, Förderung und Nutzung

Lizenzhinweise: Lizenz 1